WRN-IN-19
WRN-IN-19 (Compound (S) -27) is a covalent WRN helicase inhibitor, with pIC50 (0 h/4 h) = 5.4/7.5 in the DNA-unwinding 5 endpoint assays. WRN-IN-19 shows synthetic lethality in MSI-H (high microsatellite instability) cancer cells[1].
Product Specifications
CAS Number
[3058652-58-4]
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C(N1C[C@@H](C(N2CC3(CCC3)C2)=O)N(C(C=C)=O)CC1)CC4=CC=C(C(F)(F)F)C=C4
Molecular Formula
C23H26F3N3O3
Molecular Weight
449.47
References & Citations
[1]Sam M. Rowe, et al. ‘Direct-to-biology’ drives optimisation of a cell-active covalent inhibitor of WRN helicase
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1194297-01 0.02 mg (E-Coli)
Recombinant Mycobacterium bovis Uncharacterized protein Mb2954 (Mb2954)
Ask
View Details MBS1194297-02 0.1 mg (E-Coli)
Recombinant Mycobacterium bovis Uncharacterized protein Mb2954 (Mb2954)
Ask
View Details 
MBS1194297-03 0.02 mg (Yeast)
Recombinant Mycobacterium bovis Uncharacterized protein Mb2954 (Mb2954)
Ask
View Details MBS1194297-04 0.1 mg (Yeast)
Recombinant Mycobacterium bovis Uncharacterized protein Mb2954 (Mb2954)
Ask
View Details